pegylated liposomal doxorubicin
A form of the anticancer drug doxorubicin that may have fewer side effects and work better than doxorubicin. It is being studied in the treatment of ovarian cancer, breast cancer, Kaposi?s sarcoma, and other types of cancer. It is a type of anthracycline antitumor antibiotic. Also called liposomal doxorubicin, doxorubicin hydrochloride pegylated liposomes, Caelyx, and Doxil.